Anakinra

  • Part D specialty tier in 80% of formularies (2026Q3)
  • Biologic
  • Kineret

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Anakinra: storage and handling

Refrigerate
Yes, as the label states
Label statement
KINERET should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F).
Freezing
Do not freeze
Label statement
DO NOT FREEZE OR SHAKE.
Room temperature
No allowance stated
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

The label does not state a room-temperature allowance for this product.

Entered: 1 day at up to 77°F (25°C).

KINERET should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F).
DO NOT FREEZE OR SHAKE.

Contact the manufacturer at 1-866-547-0644 (the number printed on the label) about this product.

Where the label prints this number
For more information, go to www.kineretrx.com or call 1-866-547-0644.
All storage statements on the label (6)
  • KINERET should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F).
  • DO NOT FREEZE OR SHAKE.
  • Protect from light.
  • Store KINERET in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Do not freeze or shake KINERET.
  • Keep KINERET in its original carton and away from light.

FDA label version 24, effective April 3, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

68%of plans list it
97%of those: prior authorization
0%step therapy
62%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.